Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with Type 2 diabetes mellitus

被引:167
作者
Mishima, Y
Kuyama, A
Tada, A
Takahashi, K
Ishioka, T
Kibata, M
机构
[1] Natl Minami Okayama Hosp, Div Internal Med, Okayama 7010304, Japan
[2] Okayama Univ, Sch Med, Dept Internal Med 2, Okayama 7008558, Japan
[3] Miyamoto Hosp, Div Internal Med, Okayama 7038236, Japan
关键词
tumor necrosis factor-alpha; Type 2 diabetes mellitus; insulin resistance; obesity;
D O I
10.1016/S0168-8227(00)00247-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We analyzed serum concentrations of tumor necrosis factor-alpha. (TNF-alpha.) For their role in insulin resistance in 12 obese men with untreated Type 2 diabetes mellitus and in 6 age-and BMI-matched obese controls. Insulin resistance was expressed using the homeostasis model assessment (HOMA-R). Six of the patients were insulin-resistant (HOMA-R > 5.0), while six were not (HOMA-R less than or equal to 3.0). Serum levels of TNF-alpha were higher in patients with insulin resistance (4.19 +/- 0.96 pg/ml) than in patients without insulin resistance (2.52 +/- 1.64 pg/ml) and in controls (2.03 +/- 1.21 pg/ml). Fasting serum concentrations of insulin and HOMA-R were higher in patients with insulin resistance (16.12 +/- 5.0 and 6.30 +/- 1.0 IU/ml, respectively) than in patients without insulin resistance (7.3 +/- 2.3 and 2.4 +/- 0.6 IU/ml) and in controls (8.0 +/- 2.9 and 1.8 +/- 0.6 IU/ml). These data suggest that high levels of serum TNF-alpha in patients with insulin resistance are related to high levels of fasting insulin and HOMA-R. Wt conclude that TNF-alpha may be involved in the pathogenesis of Type 2 diabetes mellitus in obese men. The importance of this investigation is that the subjects recruited in the study are BMI matched, because human obesity is associated with an increased TNF-alpha mRNA expression in adipose tissue. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:119 / 123
页数:5
相关论文
共 16 条
[1]   INSULIN ACTION AND THE INSULIN SIGNALING NETWORK [J].
CHEATHAM, B ;
KAHN, CR .
ENDOCRINE REVIEWS, 1995, 16 (02) :117-142
[2]  
CHENING AT, 1998, ENDOCRINOLOGY, V139, P4928
[3]   Mechanisms of TNF-α-induced insulin resistance [J].
Hostamisligil, GS .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 (02) :119-125
[4]   ADIPOSE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA - DIRECT ROLE IN OBESITY-LINKED INSULIN RESISTANCE [J].
HOTAMISLIGIL, GS ;
SHARGILL, NS ;
SPIEGELMAN, BM .
SCIENCE, 1993, 259 (5091) :87-91
[5]   INCREASED ADIPOSE-TISSUE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN OBESITY AND INSULIN-RESISTANCE [J].
HOTAMISLIGIL, GS ;
ARNER, P ;
CARO, JF ;
ATKINSON, RL ;
SPIEGELMAN, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2409-2415
[6]   REDUCED TYROSINE KINASE-ACTIVITY OF THE INSULIN-RECEPTOR IN OBESITY-DIABETES - CENTRAL ROLE OF TUMOR-NECROSIS-FACTOR-ALPHA [J].
HOTAMISLIGIL, GS ;
BUDAVARI, A ;
MURRAY, D ;
SPIEGELMAN, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (04) :1543-1549
[7]  
HOTAMISLIGIL GS, 1996, CURR OPIN ENDOCRINOL, V3, P16
[8]   Evidence for a role of tumor necrosis factor α in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease [J].
Jovinge, S ;
Hamsten, A ;
Tornvall, P ;
Proudler, A ;
Båvenholm, P ;
Ericsson, CG ;
Godsland, I ;
de Faire, U ;
Nilsson, J .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (01) :113-118
[9]   HUMAN RECOMBINANT TNF SUPPRESSES LIPOPROTEIN-LIPASE ACTIVITY AND STIMULATES LIPOLYSIS IN 3T3-L1 CELLS [J].
KAWAKAMI, M ;
MURASE, T ;
OGAWA, H ;
ISHIBASHI, S ;
MORI, N ;
TAKAKU, F ;
SHIBATA, S .
JOURNAL OF BIOCHEMISTRY, 1987, 101 (02) :331-338
[10]   THE EXPRESSION OF TUMOR-NECROSIS-FACTOR IN HUMAN ADIPOSE-TISSUE - REGULATION BY OBESITY, WEIGHT-LOSS, AND RELATIONSHIP TO LIPOPROTEIN-LIPASE [J].
KERN, PA ;
SAGHIZADEH, M ;
ONG, JM ;
BOSCH, RJ ;
DEEM, R ;
SIMSOLO, RB .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2111-2119